Safety of cetirizine ophthalmic solution 0.24 for the treatment of allergic conjunctivitis in adult and pediatric subjects

摘要

PurposeThe studies reported here aimed to assess the safety and tolerability of cetirizine ophthalmic solution 0.24%, a new topical ophthalmic medication approved by the US Food and Drug Administration for the treatment of ocular itching associated with allergic conjunctivitis.